Transgene Biotek Ltd (TRABI) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Transgene Biotek Ltd reported sales of ₹0.06 Cr, operating profit of ₹-0.06 Cr (OPM -100%) and net profit of ₹-0.39 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
TRABI quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 0.06 0.08 0.08 0.05 0.05 0.05 0.05 0.06 Expenses 0.13 0.17 0.62 0.18 0.13 0.1 0.33 0.12 Operating Profit -0.07 -0.09 -0.54 -0.13 -0.08 -0.05 -0.28 -0.06 OPM -116.67% -112.5% -675% -260% -160% -100% -560% -100% Other Income 0.04 0.04 0.04 0 0 0 0.15 0 Interest 0.02 0.02 0.19 0.25 0.26 0.27 0.28 0.29 Depreciation 0.02 0.02 0.02 0.05 0.05 0.05 0.05 0.04 Profit before tax -0.07 -0.09 -0.71 -0.43 -0.39 -0.37 -0.46 -0.39 Tax 0% 0% 0% 0% 0% 0% 0% 0% Net Profit -0.07 -0.09 -0.71 -0.43 -0.39 -0.37 -0.46 -0.39 EPS in Rs -0.01 -0.01 -0.09 -0.06 -0.05 -0.05 -0.06 -0.05
TRABI profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 0.09 0.06 0.23 0.26 0.21 0.21 Expenses 0.55 0.68 0.83 1.38 0.75 0.68 Operating Profit -0.46 -0.62 -0.6 -1.12 -0.54 -0.47 OPM -511.11% -1,033.33% -260.87% -430.77% -257.14% -223.81% Other Income 0.21 0.18 0.18 0.78 0.15 0.15 Interest 0.23 0.62 0.14 0.24 1.06 1.1 Depreciation 9.92 4.95 0.09 0.09 0.2 0.19 Profit before tax -10.4 -6.01 -0.65 -0.67 -1.65 -1.61 Tax 0% 0% 0% 0% 0% - Net Profit -10.4 -6.01 -0.66 -0.68 -1.65 -1.61 EPS in Rs -1.37 -0.79 -0.09 -0.09 -0.22 -0.21 Dividend Payout 0% 0% 0% 0% 0% -
TRABI balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 75.77 75.77 75.77 75.77 75.77 Reserves -64.4 -65.06 -65.74 -66.56 -67.39 Borrowings 13.11 14 14.52 16.5 17.14 Other Liabilities 117.87 117.62 119.54 118.04 118.14 Total Liabilities 142.35 142.33 144.09 143.75 143.66 Fixed Assets 6.45 6.36 7.96 9.73 9.63 CWIP 1.87 1.87 1.87 0 0 Investments 0.1 0.1 0.1 0.1 0.09 Other Assets 133.93 134 134.16 133.92 133.94 Total Assets 142.35 142.33 144.09 143.75 143.66
TRABI cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 0.1 0 0 1.2 -0.01 Cash from Investing Activity -0.1 -0.01 0 -1.7 0.15 Cash from Financing Activity 0 0 0 0.78 -0.36 Net Cash Flow 0 -0.01 0 0.28 -0.22 Free Cash Flow 0.1 0 0 -0.5 0.14 CFO/OP -22% 0% 0% -107% 2%
TRABI ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 40.56 60.83 15.87 14.04 17.38 Inventory Days - 156.43 - - - Days Payable - 1,199.29 - - - Cash Conversion Cycle 40.56 -982.02 15.87 14.04 17.38 Working Capital Days -34,593.89 -57,365.83 -15,933.04 -16,509.23 -21,361.19 ROCE -32.31% -20.01% -2.07% -1.75% -2.36%